Latest story Refreshed every 5 minutes; wire stories every 15 minutesAbout this data
More MVPT headlines
5 articlesBioVaxys Presents Further Validation of the Robust Immune Response from a Combination of MVP-S with Checkpoint Inhibitors and Low-Dose Cyclophosphamide in Ovarian Cancer
BioVaxys Reports Positive Phase 2 Data for Maveropepimut (MVP-S) + Pembrolizumab and Low-Dose Cyclophosphamide in Metastatic Bladder Cancer
Digitalage Announces MVP Launch for Live, Creator-First Media Platform
NFL MVP Josh Allen leaves Nike to sign with New Balance
NATIONAL LEAGUE
Explore More
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers